ArticleBMC gastroenterology2025
Intestinal methanogen overgrowth and its impact on gastrointestinal disorders in children: a retrospective study.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveIntestinal methanogen overgrowth (IMO) is increasingly recognized as a contributor to gastrointestinal symptoms in children. This study aimed to investigate the clinical characteristics and endoscopic features of pediatric patients with IMO.
methodsA retrospective analysis was conducted on children with gastrointestinal symptoms hospitalized in the Department of Gastroenterology, Shanghai Children's Hospital, from September 2021 to November 2022. Patients were stratified into IMO positive and IMO negative groups based on lactulose methane breath test (LBT) results, followed by a comparative analysis of clinical characteristics between the groups. Among them, 102 patients who underwent gastroscopy and/or colonoscopy were included for analysis of endoscopic and histopathological features. Clinical information was obtained from electronic medical records.
resultsAmong 124 children with gastrointestinal symptoms, 79 (63.7%) were IMO positive. Compared to the IMO negative group (n = 45), the IMO positive group had a lower proportion of diarrhea, with a statistically significant difference (P < 0.05). Villous blunting in the terminal ileal mucosa was more prevalent in the IMO positive group (P < 0.05). No significant differences were observed in nutritional status between groups. Of 70 children ultimately diagnosed with functional gastrointestinal disorders (FGID), 48 (68.6%) were IMO positive. Among FGID patients, age distribution differed significantly between IMO positive and IMO negative groups (P < 0.05), with school-aged children predominating in the IMO positive group compared to preschool-aged and adolescent children.
conclusionsIMO positivity is prevalent in children with gastrointestinal symptoms, particularly prominent among those with FGID. The IMO positive group exhibited a lower incidence of diarrhea and more frequently demonstrated terminal ileal villous blunting. In FGID patients, IMO positivity correlates with age, showing higher rates in school-aged children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.